Furthermore, it is essential to acknowledge that CXCL13 might facilitate the onset, progression, and adverse prognosis of cancer by triggering additional oncogenic pathways, like the JAK-STAT pathway, via the chemokine pathway or cytokine receptor pathway (Zhang et al. 2022). The gene discussed is CXCL13; the disease is cancer.